<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041052/" ref="ordinalpos=1592&amp;ncbi_uid=6187486&amp;link_uid=PMC4041052" image-link="/pmc/articles/PMC4041052/figure/F9/" class="imagepopup">Figure 9.  From: Pepsin-pancreatin protein hydrolysates from extruded amaranth inhibit markers of atherosclerosis in LPS-induced THP-1 macrophages-like human cells by reducing expression of proteins in LOX-1 <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody"><b>Potential mechanism of action of the EAH by reducing expression of proteins associated with LOX-1 signaling pathway.</b> The red arrows indicate the modulation obtained in this study, for each marker, due to EAH treatment. Numbers 1, 2, 3, 4 and 5 indicate the stages of the atherosclerosis process.</div></div>